Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 3
2004 4
2005 2
2006 1
2007 1
2010 2
2011 7
2013 3
2014 5
2015 11
2016 20
2017 14
2018 13
2019 12
2020 9
2021 15
2022 14
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
ZEB1 transcription factor promotes immune escape in melanoma.
Plaschka M, Benboubker V, Grimont M, Berthet J, Tonon L, Lopez J, Le-Bouar M, Balme B, Tondeur G, de la Fouchardière A, Larue L, Puisieux A, Grinberg-Bleyer Y, Bendriss-Vermare N, Dubois B, Caux C, Dalle S, Caramel J. Plaschka M, et al. Among authors: de la fouchardiere a. J Immunother Cancer. 2022 Mar;10(3):e003484. doi: 10.1136/jitc-2021-003484. J Immunother Cancer. 2022. PMID: 35288462 Free PMC article.
ESP, EORTC, and EURACAN Expert Opinion: practical recommendations for the pathological diagnosis and clinical management of intermediate melanocytic tumors and rare related melanoma variants.
de la Fouchardiere A, Blokx W, van Kempen LC, Luzar B, Piperno-Neumann S, Puig S, Alos L, Calonje E, Massi D; ESP Dermatopathology Working Group; EORTC Melanoma Group; EURACAN. de la Fouchardiere A, et al. Virchows Arch. 2021 Jul;479(1):3-11. doi: 10.1007/s00428-020-03005-1. Epub 2021 Jan 12. Virchows Arch. 2021. PMID: 33432480
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.
Barnhill RL, Elder DE, Piepkorn MW, Knezevich SR, Reisch LM, Eguchi MM, Bastian BC, Blokx W, Bosenberg M, Busam KJ, Carr R, Cochran A, Cook MG, Duncan LM, Elenitsas R, de la Fouchardière A, Gerami P, Johansson I, Ko J, Landman G, Lazar AJ, Lowe L, Massi D, Messina J, Mihic-Probst D, Parker DC, Schmidt B, Shea CR, Scolyer RA, Tetzlaff M, Xu X, Yeh I, Zembowicz A, Elmore JG. Barnhill RL, et al. Among authors: de la fouchardiere a. JAMA Netw Open. 2023 Jan 3;6(1):e2250613. doi: 10.1001/jamanetworkopen.2022.50613. JAMA Netw Open. 2023. PMID: 36630138 Free PMC article.
Blue naevi and the blue tumour spectrum.
de la Fouchardiere A. de la Fouchardiere A. Pathology. 2023 Mar;55(2):187-195. doi: 10.1016/j.pathol.2022.12.342. Epub 2022 Dec 28. Pathology. 2023. PMID: 36641378 Review.
Genetics of adnexal tumors: An update.
Kervarrec T, Sohier P, Pissaloux D, de la Fouchardiere A, Cribier B, Battistella M, Macagno N. Kervarrec T, et al. Among authors: de la fouchardiere a. Ann Dermatol Venereol. 2023 Sep;150(3):202-207. doi: 10.1016/j.annder.2023.03.003. Epub 2023 Jun 1. Ann Dermatol Venereol. 2023. PMID: 37270318 Review.
Recurrent FOXK1::GRHL and GPS2::GRHL fusions in trichogerminoma.
Kervarrec T, Pissaloux D, Poilane J, Tirode F, Tallet A, Collin C, Tallegas M, Berthon P, Gaboriaud P, Sohier P, Calonje E, Luzar B, Goto K, Cokelaere K, Lamant L, Balme B, Wild R, Neuville A, Deschamps L, Auberger E, Paumier V, Bonte H, Moulonguet I, Plantier F, Cales V, Pinsolle V, Roblet D, Dupuy F, Dallot A, Seris A, Jouary T, Houben R, Schrama D, Hesbacher S, Macagno N, Battistella M, Cribier B, Vergier B, de la Fouchardière A, Jullie ML. Kervarrec T, et al. Among authors: de la fouchardiere a. J Pathol. 2022 May;257(1):96-108. doi: 10.1002/path.5872. Epub 2022 Mar 28. J Pathol. 2022. PMID: 35049062
Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation.
Kervarrec T, Pissaloux D, Paindavoine S, Tirode F, Osio A, Mourah S, Jouenne F, Sohier P, Calonje E, Pekar A, Luna EVE, Goto K, Delalande F, Frouin E, Macagno N, Drouot F, Faisan M, Cribier B, Battistella M, de la Fouchardière A. Kervarrec T, et al. Among authors: de la fouchardiere a. Histopathology. 2023 Aug;83(2):310-319. doi: 10.1111/his.14940. Epub 2023 May 18. Histopathology. 2023. PMID: 37199682
The International Collaboration for Cancer Classification and Research.
Cree IA, Indave Ruiz BI, Zavadil J, McKay J, Olivier M, Kozlakidis Z, Lazar AJ, Hyde C, Holdenrieder S, Hastings R, Rajpoot N, de la Fouchardiere A, Rous B, Zenklusen JC, Normanno N, Schilsky RL; IC3R participants. Cree IA, et al. Among authors: de la fouchardiere a. Int J Cancer. 2021 Feb 1;148(3):560-571. doi: 10.1002/ijc.33260. Epub 2020 Oct 9. Int J Cancer. 2021. PMID: 32818326 Free PMC article.
136 results